Showing 2 of 2 recruiting trials for “Autosomal dominant generalized epidermolysis bullosa simplex, intermediate form”
A 20-Week Study Assessing the Efficacy of Apremilast in Patients with EB Simplex Generalized
An International, Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled, Phase 2/3 Study With Open-Label Extension Evaluating the Efficacy and Safety of Diacerein 1% Ointment for the Treatment of Generalized Epidermolysis Bullosa Simplex (EBS)
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →